Purchase Order 75N93018P00675
Award Date 5/8/18
Potential Completion Date 5/7/19
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a $20,591.00 firm fixed-price purchase order to Proteos Inc. for custom protein purification and expression services. The contract has an ultimate completion date of April 17, 2015. Proteos Inc. is a for-profit organization that specializes in producing high-quality recombinant proteins, particularly HIV-related proteins, for federal agencies like the Centers for Disease...
- This federal contract was awarded by the Plains Area division of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $3,458.11 firm fixed-price purchase order is for protein expression and purification services. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from federal agencies like the Department of Health and Human Services (including the National Institutes of Health, Centers...
- Genscript USA Inc., a biotechnology firm headquartered in Piscataway, New Jersey, was awarded a $3,409.09 firm fixed-price purchase order by the Plains Area civilian agency on April 28, 2021, with completion due by June 28, 2021. The contract involves customized protein production utilizing the baculovirus expression system at a 5-liter expression level, with baculovirus constructs provided by the contracting agency. The deliverables include one-step protein purification and quality control...
- The U.S. civilian Northeast Area agency awarded a $35.7K firm fixed-price purchase order to Biomatik USA, LLC for custom protein production services. The contract was awarded on September 20, 2021, with an ultimate completion date of October 20, 2021. The work is to be performed at the contractor's facility in Frederick, Maryland. This contract represents a continuation of Biomatik's relationship with federal research agencies, as the company has previously provided custom protein, peptide,...
- The U.S. government awarded a $2,656 firm fixed-price purchase order to Genscript USA Inc. for molecular biology services on July 28, 2018, with an ultimate completion date of August 15, 2018. The contract, issued by the Pacific West Area civilian agency, calls for the synthesis of a CAMV 35S promoter followed by a CTV-RB115 sequence consisting of 5,711 base pairs and the cloning of this sequence in pBluescript II SK(+) vector. The work will be performed at Genscript's facility in Piscataway,...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $40,505 firm-fixed-price purchase order to Charles River Laboratories, Inc. to perform characterization testing of Pichia master and working cell banks. This work supports ongoing research at the Laboratory of Malaria Immunology and Vaccinology to develop a malaria transmission-blocking vaccine candidate. The testing will demonstrate the identity, purity,...
- The U.S. government awarded a $3,681.17 firm fixed-price purchase order to Genscript USA Inc. for protein synthesis services on April 8, 2019, with a completion date of May 31, 2019. The contract was issued by a civilian federal agency within the Pacific West Area and will be performed at Genscript's headquarters in Piscataway, New Jersey. No set-aside designation was applied to this award, making it available to all qualified vendors in full and open competition. Genscript USA Inc., a...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Proteos Inc., a for-profit organization specializing in the production of recombinant proteins. The $24,248.00 contract is for the expression and purification of OTSA and OTSB proteins in insect cells, with a target of 7.5 mg of OTSA and 2.5 mg of OTSB at a purity greater than 90% and low endotoxin levels. The contract has an...
- This federal contract award, valued at $5,805.81, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, which is a firm fixed-price purchase order, is for the provision of a "GENE-TO-PROTEIN PACKAGE, PFC1045C" and has an ultimate completion date of March 4, 2011. Genscript USA Inc. is a for-profit organization that...
- MS Bioworks LLC, a specialized biomedical research services firm based in Ann Arbor, Michigan, was awarded a $30,000 firm fixed-price purchase order by the Pacific West Area (civilian agency) on July 23, 2021, to conduct proteomics analysis on barley malt samples. This contract is designated as a Total Small Business set-aside and represents a continuation of previous work under Purchase Order 12020219P0005. The work is to be performed in Aberdeen, Idaho, with an ultimate completion date of...
WHEAT-GERM CELL-FREE PROTEIN PRODUCTION AND PURIFICATION SERVICES FOR MALARIA PROTEINS
Posted 5/8/18
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
a Novel Wheat germ cell-free protein production and purification services for Malaria PfHAP2 (4mg) and HisGST (I mg) proteins | NOI-NIAID-1904892 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 4/24/18, 5:07 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 5/8/18 |